Preferred Rivals: Express Scripts Covers Both Repatha And Praluent
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacy benefit manager will cover both Amgen’s Repatha (evolocumab) and Regeneron/Sanofi’s Praluent(alirocumab) instead of picking a preferred PCSK9 inhibitor, as it did for hepatitis C.